Are there any antirheumatic drugs that modify the course of ankylosing spondylitis?

Amor, 1984, Sulfasalazine and ankylosing spondylitis, Annals of Internal Medicine, 101, 878, 10.7326/0003-4819-101-6-878_1 Ball, 1980, Pathology and pathogenesis, 96 Bird, 1977, Failure of d-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA-B27 associated arthropathy, Annals of the Rheumatic Diseases, 36, 289, 10.1136/ard.36.3.289 Burgos-Vargas, 1989, Ankylosing spondylitis in the Mexican mestizo: patterns of disease onset according to age of onset, Journals of Rheumatology, 16, 186 Calabro, 1966, Management of ankylosing spondylitis, Bulletin on the Rheumatic Diseases, 16, 408 Calman, 1980, The present position of radiotherapy, 243 Calin, 1989, Retrospective analysis of 376 irradiated patients with ankylosing spondylitis and nonirradiated controls, Journal of Rheumatology, 16, 1443 Coelho-Andrade, 1989, Sulphasalazine and ankylosing spondylitis: an open pilot study, Clinical and Experimental Rheumatology, 7, 661 Comer, 1988, In vitro immuno-modulatory effects of sulphasalazine and its metabolites, Journal of Rheumatology, 15, 580 Corkill, 1990, A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect, British Journal of Rheumatology, 29, 41, 10.1093/rheumatology/29.1.41 Darby, 1987, Long term mortality after a single treatment course with x-rays in patients treated for ankylosing spondylitis, British Journal of Cancer, 55, 179, 10.1038/bjc.1987.35 Davis, 1989, Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1 antitrypsin, British Journal of Rheumatology, 28, 410, 10.1093/rheumatology/28.5.410 Desmarais, 1953, Radiotherapy in arthritis, Annals of the Rheumatic Diseases, 12, 25, 10.1136/ard.12.1.25 Docker, 1989, Low dose prednisone therapy, Rheumatic Disease Clinics of North America, 15, 569, 10.1016/S0889-857X(21)01009-7 Dougados, 1986, Sulphasalazine in ankylosing spondylitis: a double blind controlled study in sixty patients, British Medical Journal, 293, 911, 10.1136/bmj.293.6552.911 Ejstrup, 1985, Intravenous methylprednisolone pulse therapy in ankylosing spondylitis, Danish Medical Bulletin, 32, 231 Feltelius, 1986, Sulphasalazine in ankylosing spondylitis, Annals of the Rheumatic Diseases, 45, 396, 10.1136/ard.45.5.396 Franssen, 1985, IgA serum levels and disease activity in ankylosing spondylitis: a prospective study, Annals of the Rheumatic Diseases, 44, 766, 10.1136/ard.44.11.766 Fraser, 1990, Evaluation of sulphasalazine in ankylosing spondylitis—an interventional study, British Journal of Rheumatology, 29, 37, 10.1093/rheumatology/29.1.37 Goebel, 1977, Levamisole-induced immunostimulation in spondyloarthropathies, Lancet, ii, 214, 10.1016/S0140-6736(77)92833-1 Golding, 1974, d-penicillamine in ankylosing spondylitis and polymyositis, Postgraduate Medical Journal, 50, 62 Grill, 1988, Local radiotherapy for pedal manifestation of HLA-B27 related arthropathy, British Journal of Rheumatology, 27, 390, 10.1093/rheumatology/27.5.390 Handler, 1989, Favourable results using methotrexate in the treatment of patients with ankylosing spondylitis, Arthritis and Rheumatism, 32, 234, 10.1002/anr.1780320221 Hart, 1980, Clinical features and complications Hill, 1980, Drug therapy, 163 Iglehart, 1990, Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study, Journal of Rheumatology, 17, 159 Laurent, 1983, Acute phase proteins and serum immunoglobulins in ankylosing spondylitis, Annals of the Rheumatic Diseases, 42, 524, 10.1136/ard.42.5.524 Laurent, 1990, Methods of assessment used in ankylosing spondylitis clinical trials: a review, British Journal of Rheumatology MacDermott, 1989, Inhibition of antibody secretion by 5-aminosalicylic acid, Gastroenterology, 96, 442, 10.1016/0016-5085(89)91569-2 Mander, 1987, Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis, Annals of the Rheumatic Diseases, 46, 197, 10.1136/ard.46.3.197 Mau, 1988, Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10 year follow-up, Journal of Rheumatology, 15, 1109 Mielants, 1986, Sulphasalazine in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis, Clinical Rheumatology, 5, 80, 10.1007/BF02030973 Mielants, 1988, Ileocolonoscopic findings in seronegative spondyloarthropathies, British Journal of Rheumatology, 27, 95, 10.1093/rheumatology/XXVII.suppl_2.95 Mintz, 1981, Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis, Arthritis and Rheumatism, 24, 734, 10.1002/art.1780240521 Moll, 1985, Inflammatory bowel disease, Clinics in Rheumatic Diseases, 11, 87, 10.1016/S0307-742X(21)00590-7 Nashel, 1986, C-Reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome, Journal of Rheumatology, 13, 364 Nissila, 1988, Sulphasalazine in the treatment of ankylosing spondylitis, Arthritis and Rheumatism, 31, 1111, 10.1002/art.1780310905 Pile, 1990, Clinical assessment of ankylosing spondylitis. A study of observer variation in spinal assessments, British Journal of Rheumatology Ralston, 1990, Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis, British Medical Journal, 300, 563, 10.1136/bmj.300.6724.563 Richter, 1983, The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis, Clinical and Experimental Immunology, 53, 51 Rosenthal, 1976, Immunotherapy with levamisole in rheumatic diseases, Scandinavian Journal of Rheumatology, 5, 216, 10.3109/03009747609099908 Sadowska-Wroblewska, 1986, A trial of cyclophosphamide in ankylosing spondylitis with involvement of peripheral joints and high disease activity, Scandinavian Journal of Rheumatology, 15, 259, 10.3109/03009748609092589 Sanders, 1987, Correlation of immunoglobulin and C-reactive protein levels in ankylosing spondylitis and rheumatoid arthritis, Annals of the Rheumatic Diseases, 46, 273, 10.1136/ard.46.4.273 Scharf, 1976, Penicillamine in ankylosing spondylitis, Arthritis and Rheumatism, 19, 122, 10.1002/art.1780190123 Scott, 1981, Problems in the assessment of disease activity in ankylosing spondylitis, Rheumatology and Rehabilitation, 20, 74, 10.1093/rheumatology/20.2.74 Sheehan, 1986, Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase protein or protease inhibitors in ankylosing spondylitis, British Journal of Rheumatology, 25, 171, 10.1093/rheumatology/25.2.171 Sinclair, 1971, Treatment of rheumatic disorders with special reference to ankylosing spondylitis, 64, 1031 Smythe, 1979, Therapy of the spondyloarthropathies, Clinical Orthopaedics and Related Research, 143, 84 Steven, 1985, Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial, Journal of Rheumatology, 12, 735 Taylor, 1989, Sulphasalazine in ankylosing spondylitis-effective in early disease?, British Journal of Rheumatology, 28, 6 Tytman, 1989, d-penicillamine in the therapy of ankylosing spondylitis, Clinical Rheumatology, 8, 419, 10.1007/BF02030361 Ward, 1963, Rheumatoid spondylitis, Arthritis and Rheumatism, 6, 650, 10.1002/art.1780060509 Wilkinson, 1958, Clinical features and course of ankylosing spondylitis, Annals of the Rheumatic Diseases, 17, 209, 10.1136/ard.17.2.209 Will, 1989, Ankylosing spondylitis is associated with masked osteopeania of the lumbar spine and femoral neck in patient with mobile spines and normal hips, British Journal of Rheumatology, 28, 19 Will, 1989, Ankylosing spondylitis and acute phase reactant: a measure of peripheral joint inflammation—not axial disease, British Journal of Rheumatology, 28, 11